Profil
Helle Størum worked as a Principal at H.
Lundbeck A from 2007 to 2016.
She then worked as a Director of Business Development at Zealand Pharma A from 2016 to 2017, and at Pharmacosmos A from 2017 to 2020.
She also worked as a Principal at Takeda A. Currently, she is the Head of Business Development at Amniotics AB since 2020.
Ms. Størum holds a Master's degree in Business Administration from the University of Southern Denmark.
Tidigare kända positioner av Helle Størum
| Företag | Position | Slut |
|---|---|---|
| AMNIOTICS AB | Företagsledare/Principal | 2023-12-01 |
Pharmacosmos A/S
Pharmacosmos A/S BiotechnologyHealth Technology Engages in development of treatments for patients suffering from iron deficiency and anemia | Företagsledare/Principal | 2020-01-01 |
| ZEALAND PHARMA A/S | Direktör/Styrelseledamot | 2016-04-19 |
| H. LUNDBECK A/S | Företagsledare/Principal | 2016-03-01 |
Takeda A/S
Takeda A/S Financial ConglomeratesFinance Engages in holding or owning securities of companies | Företagsledare/Principal | - |
Utbildning av Helle Størum
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 6 |
|---|---|
H. Lundbeck A/S
H. Lundbeck A/S Pharmaceuticals: MajorHealth Technology Engages in the research, development, production and sale of pharmaceuticals for the treatment of brain diseases | Health Technology |
Zealand Pharma A/S
Zealand Pharma A/S BiotechnologyHealth Technology Operates as a biotechnology company that discovers and develops peptide based medicines | Health Technology |
Takeda A/S
Takeda A/S Financial ConglomeratesFinance Engages in holding or owning securities of companies | Finance |
University of Southern Denmark
University of Southern Denmark Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pharmacosmos A/S
Pharmacosmos A/S BiotechnologyHealth Technology Engages in development of treatments for patients suffering from iron deficiency and anemia | Health Technology |
Amniotics AB
Amniotics AB BiotechnologyHealth Technology Develops stem cell-based therapeutics for the treatment of human diseases | Health Technology |
















